Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Total Liabilities (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Total Liabilities for 16 consecutive years, with $20.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Liabilities fell 26.77% year-over-year to $20.5 million, compared with a TTM value of $20.5 million through Sep 2025, down 26.77%, and an annual FY2024 reading of $26.6 million, down 13.79% over the prior year.
  • Total Liabilities was $20.5 million for Q3 2025 at Rockwell Medical, down from $22.2 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $47.6 million in Q3 2021 and bottomed at $20.5 million in Q3 2025.
  • Average Total Liabilities over 5 years is $33.3 million, with a median of $30.9 million recorded in 2023.
  • The sharpest move saw Total Liabilities grew 10.3% in 2021, then plummeted 33.88% in 2023.
  • Year by year, Total Liabilities stood at $46.0 million in 2021, then fell by 29.34% to $32.5 million in 2022, then fell by 5.06% to $30.9 million in 2023, then fell by 13.79% to $26.6 million in 2024, then dropped by 23.12% to $20.5 million in 2025.
  • Business Quant data shows Total Liabilities for RMTI at $20.5 million in Q3 2025, $22.2 million in Q2 2025, and $22.4 million in Q1 2025.